|
Title
|
Published
|
Price
|
By
GlobalData
Ipsen Biopharmaceuticals, Inc., (Ipsen), formerly known as Tercica, Inc., is a biotechnology company. It identifies and commercializes products in therapy areas such as, endocrinology and neurology. The company''s product portfolio includes, Increlex,
|
May
2013
|
$
125
|
By
World Market Intelligence
SynopsisThe Biocon - Bio X-cell Biopharmaceutical Manufacturing and R&D Facility - Johor - Construction Project Profile contains information on the scope of the project including project overview and location. The profile also details project owners
|
April
2013
|
$
75
|
By
World Market Intelligence
SynopsisThe NVO - Kalundborg New Biopharmaceutical Production Facility - Denmark - Construction Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership and
|
April
2013
|
$
75
|
By
GlobalData
SK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals) is a Korea-based biopharmaceutical company. It undertakes the development of innovative next-generation drugs in the field of central nervous system (CNS) and metabolic diseases. The company ope
|
March
2013
|
$
250
|
By
GlobalData
Kythera Biopharmaceuticals, Inc. (KYTHERA) is a bio-pharmaceutical company, based in the US. It discovers, develops and commercializes novel prescription products for the aesthetic medicine market. The company’s product ATX-101, an injectable drug is
|
March
2013
|
$
250
|
By
GlobalData
Nabi Biopharmaceuticals (Nabi) is a a bio-pharmaceutical company with focus on the development and marketing of vaccines for the treatment of serious medical conditions in the field of nicotine addiction and infectious disease. The company''s lead pro
|
March
2013
|
$
250
|
By
GlobalData
Accentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of chronic and life threatening diseases including the respirato
|
March
2013
|
$
250
|
By
GlobalData
Navidea Biopharmaceuticals, Inc. (Navidea) is a biopharmaceutical company with the focus on the development and commercialization of radiopharmaceutical agent and precision diagnostics. The company''s development product in the pipeline include Lympho
|
March
2013
|
$
250
|
By
GlobalData
This comprehensive SWOT profile of Kythera Biopharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of t
|
March
2013
|
$
300
|
By
IMARC Group
The global biopharmaceutical Industry has come a long way since its first drug - Humulin was approved in 1982. Today more than three hundred biopharmaceuticals have already been approved and many more are in late stages of clinical development. Th...
|
September
2012
|
$
1200
|
By
GlobalData
Alder Biopharmaceuticals Inc. (Alder) is a healthcare service providing company, based in the US. It develops antibody therapeutics for the treatment of cancer, rheumatoid arthritis, and anemia. The company’s antibody therapeutic pipeline includes AL
|
August
2012
|
$
250
|
By
GlobalData
3P Biopharmaceuticals S.L. (3PB) is a contract manufacturing organization, based in Spain. The company manufactures biopharmaceutical products. It produces therapeutic proteins for laboratories and pharmaceutical companies that are used in pharmaceut
|
August
2012
|
$
250
|
By
GlobalData
Huifeng BioPharmaceutical Technology Inc. (Huifeng) is a biopharmaceutical company, based in China. The company develops, produces and sells plant extracts, pharmaceuticals and pharmaceutical raw materials in China and internationally. Its pharmaceut
|
August
2012
|
$
250
|
By
World Market Intelligence
SynopsisThe GSK - GlaxoSmithKline Biopharmaceutical Plant - Cumbria - Construction Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, give
|
July
2012
|
$
75
|
By
Global Markets Direct
Morria Biopharmaceuticals Plc – Product Pipeline Review – 2012
Summary
Global Market Direct’s pharmaceuticals report, “Morria Biopharmaceuticals Plc - Product Pipeline Review - 2012” provides data on the Morria Biopharmaceuticals Plc’s research
|
June
2012
|
$
500
|
By
GlobalData
This comprehensive SWOT profile of Huifeng BioPharmaceutical Technology Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased
|
June
2012
|
$
250
|
By
MarketLine
Nabi Biopharmaceuticals - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚
|
December
2011
|
$
150
|
By
Global Markets Direct
Global Market Direct’s pharmaceuticals report, “Nabi Biopharmaceuticals - Product Pipeline Review - H2 2011” provides data on the Nabi Biopharmaceuticals’s research and development focus. The report includes information on current developmental pipel
|
November
2011
|
$
500
|
By
Global Markets Direct
Global Market Direct’s pharmaceuticals report, “Keryx Biopharmaceuticals, Inc. - Product Pipeline Review - H2 2011” provides data on the Keryx Biopharmaceuticals, Inc.’s research and development focus. The report includes information on current devel
|
October
2011
|
$
500
|
By
GlobalData
Report SummaryXTL Biopharmaceuticals Ltd. (XTL) is a publicly held engaged in the acquisition, development and commercialization of therapeutics for the treatment of multiple myeloma and hepatitis C. Recombinant Eryth...
|
September
2011
|
$
250
|
By
Global Markets Direct
Global Market Direct’s pharmaceuticals report, “Inspiration Biopharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the comp...
|
May
2011
|
$
500
|
By
Global Markets Direct
Global Market Direct’s pharmaceuticals report, “Nabi Biopharmaceuticals - Product Pipeline Review - Q1 2011” provides data on the company’s research and develop...
|
March
2011
|
$
500
|
By
Global Markets Direct
Global Market Direct’s pharmaceuticals report, “Keryx Biopharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s resear...
|
March
2011
|
$
500
|
By
Datamonitor
Datamonitor's Nabi Biopharmaceuticals - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offeri...
|
March
2011
|
$
125
|
By
Life Science Analytics
Report contains the company’s contact information, business , company details, tables, graphs and listings of the number of deals by deal category (product, technology, miscellaneo...
|
March
2011
|
$
600
|
By
Life Science Analytics
Report contains the company’s contact information, business , company details, tables, graphs and listings of the number of deals by deal category (produ...
|
March
2011
|
$
600
|
By
Life Science Analytics
Report contains the company’s contact information, business , company details, tables, graphs and listings of the number of deals by d...
|
March
2011
|
$
600
|
By
Life Science Analytics
provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records.
March
2011
|
$
750
|
|
By
Life Science Analytics
provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records...
|
March
2011
|
$
750
|
By
Life Science Analytics
provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records....
|
March
2011
|
$
750
|
By
Life Science Analytics
provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records.
March
2011
|
$
750
|
|
By
Life Science Analytics
provides up to date insight into company’s business description, product information, pipeline details including both information and detailed individual product records....
|
March
2011
|
$
750
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication ...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and s...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and ...
|
March
2011
|
$
350
|
By
Life Science Analytics
Report includes a business , tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication an...
|
March
2011
|
$
350
|